Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Healthcare Resource Utilization and Sickness Absence in Newly Diagnosed Multiple Myeloma Patients in Sweden: Trends in a Changing Treatment Landscape

Fredrik Borgsten, MD, Xenia Gatopoulou, MBA, Marta Pisini, MBA, Magnus Tambour, PhD, Frida Schain, PhD, Christina V Jones, PhD, Kelvin Ho Man Kwok, PhD, Catharina Hjortsberg, PhD, Magnus Björkholm, MD PhD

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-137498

Published: 2020

Journal Articles

Diabetes Mellitus and Risk of Plasma Cell and Lymphoproliferative Disorders: A Population Based Study Including 94,579 Cases and 368,348 Matched Controls

Urvi A Shah, MD, Sæmundur Rögnvaldsson, BS, Andriy Derkach, PhD, Magnus Björkholm, MD PhD, Ingemar Turesson, MD PhD, Yael David, PhD, Malin Hultcrantz, MD PhD, Carlyn Tan, MD, Hani Hassoun, MD, Neha Korde, MD, Alexander M. Lesokhin, MD, Sham Mailankody, MBBS, Sigurður Yngvi Kristinsson, MD PhD, Ola Landgren, MD PhD

Blood (2020) 136 (Supplement 1): 44–45.

https://doi.org/10.1182/blood-2020-141597

Published: 2020

Journal Articles

Peripheral Neuropathy in MGUS and Progression to Amyloid Light-Chain Amyloidosis: A Population-Based Study Including 15,351 MGUS Cases

Sæmundur Rögnvaldsson, MD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2019) 134 (Supplement_1): 5444.

https://doi.org/10.1182/blood-2019-131514

Published: 2019

Journal Articles

Risk Factors for Acute Myeloid Leukemia and Myelodysplastic Syndromes in Patients with Multiple Myeloma: An Updated Analysis

Gudbjorg Jonsdottir, MD, Magnus Björkholm, MD PhD, Ingemar Turesson, MD PhD, Malin Hultcrantz, MD PhD, Anna Porwit, MD PhD, Yogesh Jethava, MBBS, MD FRCPath, MRCP, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2018) 132 (Supplement 1): 4437.

https://doi.org/10.1182/blood-2018-99-111715

Published: 2018

Journal Articles

The Impact of Fractures on Survival in Multiple Myeloma: Results from a Population-Based Study

Sigrun Thorsteinsdottir, MD, Ingigerdur S Sverrisdottir, MD, Gauti Gislason, MSc, Ola Landgren, MD PhD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Sigurdur Y Kristinsson, MD PhD

Blood (2018) 132 (Supplement 1): 4490.

https://doi.org/10.1182/blood-2018-99-115403

Published: 2018

Journal Articles

Peripheral Neuropathy Is Associated with an Increased Risk of Fractures in Individuals with Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study Including 15,351 MGUS Cases

Sæmundur Rögnvaldsson, BS, Sigrun Thorsteinsdottir, MD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2018) 132 (Supplement 1): 1914.

https://doi.org/10.1182/blood-2018-99-116740

Published: 2018

Journal Articles

Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors

Gudbjorg Jonsdottir, MD, Magnus Bjorkholm, MD PhD, Ingemar Turesson, MD PhD, Malin Hultcrantz, MD PhD, Anna Porwit, MD PhD, Yogesh Jethava, MBBS,MDFRCPath,MRCP, Ola Landgren, MD PhD, Sigurdur Y. Kristinsson, MD PhD

Blood (2017) 130 (Supplement 1): 4396.

https://doi.org/10.1182/blood.V130.Suppl_1.4396.4396

Published: 2017

Journal Articles

Peripheral Neuropathy Is an Under-Recognized Feature of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 18,668 MGUS Patients and Their 97,641 Matched Controls

Sæmundur Rögnvaldsson, Vilhjálmur Steingrímsson, MD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Ola Landgren, MD PhD, Sigurður Yngvi Kristinsson, MD PhD

Blood (2017) 130 (Supplement 1): 4338.

https://doi.org/10.1182/blood.V130.Suppl_1.4338.4338

Published: 2017

Journal Articles

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

Gudbjorg Jonsdottir, MD, Sigrún H. Lund, PhD, Magnus Björkholm, MD, PhD, Ingemar Turesson, MD, PhD, Anders Wahlin, MD, Prof., Malin Hultcrantz, MD, PhD, Anna Porwit, MD, PhD, Ola Landgren, MD, PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 3246.

https://doi.org/10.1182/blood.V128.22.3246.3246

Published: 2016

Journal Articles

Risk of Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS): Results from a Population-Based Screening Study

Ebba K Lindqvist, MD, Sigrun H Lund, PhD, Rene Costello, Debra Burton, Neha S Korde, MD, Sham Mailankody, MD, Magnus Björkholm, MD, PhD, Gudny Eiriksdottir, Leonore J Launer, PhD, Tamara B Harris, MD, Malin Hultcrantz, MDPhD, Vilmundur Gudnason, MD PhD, Ola Landgren, MD PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2016) 128 (22): 5650.

https://doi.org/10.1182/blood.V128.22.5650.5650

Published: 2016

Journal Articles

Risk of Bleeding in 9,429 Patients with Philadelphia-Negative Myeloproliferative Neoplasms: a Population-Based Study from Sweden

Maria Creignou, MD, Hannah Bower, MSc, Therese M-L Andersson, MSc PhD, Anna Ravn Landtblom, MD, Paul W Dickman, MSc PhD, Magnus Björkholm, MD, PhD, Sigurdur Y Kristinsson, MD, PhD, Malin Hultcrantz, MDPhD

Blood (2016) 128 (22): 946.

https://doi.org/10.1182/blood.V128.22.946.946

Published: 2016

Journal Articles

Temporal Trends in Chronic Myeloid Leukemia Outcome Using the Loss in Expectation of Life: A Swedish Population-Based Study

Magnus Bjorkholm, MD PhD, Hannah Bower, Paul W Dickman, MSc PhD, Paul C Lambert, PhD, Martin Höglund, MD PhD, Therese M-L Andersson, PhD

Blood (2015) 126 (23): 2779.

https://doi.org/10.1182/blood.V126.23.2779.2779

Published: 2015

Journal Articles

No Risk of Arterial or Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance: Results from a Population-Based Study

Ebba K Lindqvist, MD, Sigrún H. Lund, PhD, Rene Costello, Debra Burton, Neha S Korde, MD, Sham Mailankody, MBBS, Vilmundur Gudnason, MD PhD, Gudny Eiriksdottir, Leonore Launer, PhD, Tamara B Harris, MD, Malin Hultcrantz, MDPhD, Ola Landgren, MD PhD, Sigurdur Y Kristinsson, MD PhD, Magnus Bjorkholm, MD PhD

Blood (2015) 126 (23): 4252.

https://doi.org/10.1182/blood.V126.23.4252.4252

Published: 2015

Journal Articles

Increased Prevalence of Prior Malignancies and Autoimmune Diseases in Patients Diagnosed with Chronic Myeloid Leukemia

Niklas Gunnarsson, MD, Martin Hoglund, MD PhD, Leif Stenke, MD PhD, Solveig Wallberg Jonsson, MD PhD, Fredrik Sandin, PhD, Magnus Bjorkholm, MD PhD, Arta Dreimane, MD PhD, Mats Lambe, MD PhD, Berit Markevarn, MD, Ulla Olsson-Stromberg, MD PhD, Hans Wadenvik, MD PhD, Johan Richter, MD PhD, Anders Sjalander, MD PhD

Blood (2015) 126 (23): 1586.

https://doi.org/10.1182/blood.V126.23.1586.1586

Published: 2015

Journal Articles

A Population-Based Study of Incidence of Myeloproliferative Neoplasms in Sweden Between 2000 and 2012

Malin Hultcrantz, MDPhD, Therese M-L Andersson, MSc PhD, Ola Landgren, MD PhD, Paul W Dickman, MSc PhD, Bjorn Andreasson, MDPhD, Magnus Bjorkholm, MD PhD, Sigurdur Y Kristinsson, MD PhD

Blood (2015) 126 (23): 1605.

https://doi.org/10.1182/blood.V126.23.1605.1605

Published: 2015

Journal Articles

Patterns of Infectious Morbidity in Patients with Waldenström’s Macroglobulinaemia/Lymphoplasmacytic Lymphoma: A Population-Based Study

Sigrun Helga Lund, PhD, Malin Hultcrantz, MDPhD, Lynn Goldin, PhD, Ola Landgren, MD PhD, Magnus Björkholm, MD PhD, Ingemar Turesson, MD PhD, Sigurdur Y Kristinsson, MD, Ph., D

Blood (2014) 124 (21): 3350.

https://doi.org/10.1182/blood.V124.21.3350.3350

Published: 2014

Journal Articles

Increased Risk of Cardiovascular Events Associated with TKI Treatment in Chronic Phase Chronic Myeloid Leukemia. Data from Swedish Population-Based Registries

Torsten Dahlén, MD, Gustaf Edgren, MD PhD, Martin Höglund, MD PhD, Mats Lambe, MD PhD, Magnus Björkholm, MD PhD, Fredrik Sandin, PhD, Anders Själander, MD PhD, Johan Richter, MD PhD, Lotta Ohm, MD PhD, Magnus Bäck, MD PhD, Leif Stenke, MD PhD

Blood (2014) 124 (21): 3134.

https://doi.org/10.1182/blood.V124.21.3134.3134

Published: 2014

Journal Articles

Survival from Acute Lymphoblastic Leukemia (ALL) in Adult Patients in the United States and Sweden: Evidence of Recent Improvement

Edgren Gustaf, MDPhD, Magnus Björkholm, MD PhD, Per Bernell, MDPhD, Helene Hallböök, MDPhD, Paul W Dickman, PhD

Blood (2014) 124 (21): 938.

https://doi.org/10.1182/blood.V124.21.938.938

Published: 2014

Journal Articles

Risk of Arterial and Venous Thrombosis in 11,155 Patients with Myeloproliferative Neoplasms and 44,620 Matched Controls; A Population-Based Study

Malin Hultcrantz, MDPhD, Therese M-L Andersson, PhD, Ola Landgren, MD, PhD, Asa Rangert Derolf, MDPhD, Paul W Dickman, PhD, Magnus Björkholm, MD PhD, Sigurdur Y Kristinsson, MD, PhD

Blood (2014) 124 (21): 632.

https://doi.org/10.1182/blood.V124.21.632.632

Published: 2014

Journal Articles

Eighteen Years Experience of Granulocyte Donations - Acceptable Donor Safety?

Ulla Axdorph Nygell, MD PhD, Agneta Sollén-Nilsson, RN, Magnus Bjorkholm, MD PhD, Joachim Lundahl, MD PhD

Blood (2014) 124 (21): 5819.

https://doi.org/10.1182/blood.V124.21.5819.5819

Published: 2014

NARROW

Healthcare Resource Utilization and Sickness Absence in Newly Diagnosed Multiple Myeloma Patients in Sweden: Trends in a Changing Treatment Landscape

Diabetes Mellitus and Risk of Plasma Cell and Lymphoproliferative Disorders: A Population Based Study Including 94,579 Cases and 368,348 Matched Controls

Peripheral Neuropathy in MGUS and Progression to Amyloid Light-Chain Amyloidosis: A Population-Based Study Including 15,351 MGUS Cases

Risk Factors for Acute Myeloid Leukemia and Myelodysplastic Syndromes in Patients with Multiple Myeloma: An Updated Analysis

The Impact of Fractures on Survival in Multiple Myeloma: Results from a Population-Based Study

Peripheral Neuropathy Is Associated with an Increased Risk of Fractures in Individuals with Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study Including 15,351 MGUS Cases

Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) after Multiple Myeloma: Assessment of Risk Factors

Peripheral Neuropathy Is an Under-Recognized Feature of Monoclonal Gammopathy of Undetermined Significance: A Population-Based Study of 18,668 MGUS Patients and Their 97,641 Matched Controls

The Impact of Prior Malignancies on Second Malignancies and Survival in MM Patients: A Population-Based Study

Risk of Progression in Monoclonal Gammopathy of Undetermined Significance (MGUS): Results from a Population-Based Screening Study

Risk of Bleeding in 9,429 Patients with Philadelphia-Negative Myeloproliferative Neoplasms: a Population-Based Study from Sweden

Temporal Trends in Chronic Myeloid Leukemia Outcome Using the Loss in Expectation of Life: A Swedish Population-Based Study

No Risk of Arterial or Venous Thrombosis in Monoclonal Gammopathy of Undetermined Significance: Results from a Population-Based Study

Increased Prevalence of Prior Malignancies and Autoimmune Diseases in Patients Diagnosed with Chronic Myeloid Leukemia

A Population-Based Study of Incidence of Myeloproliferative Neoplasms in Sweden Between 2000 and 2012

Patterns of Infectious Morbidity in Patients with Waldenström’s Macroglobulinaemia/Lymphoplasmacytic Lymphoma: A Population-Based Study

Increased Risk of Cardiovascular Events Associated with TKI Treatment in Chronic Phase Chronic Myeloid Leukemia. Data from Swedish Population-Based Registries

Survival from Acute Lymphoblastic Leukemia (ALL) in Adult Patients in the United States and Sweden: Evidence of Recent Improvement

Risk of Arterial and Venous Thrombosis in 11,155 Patients with Myeloproliferative Neoplasms and 44,620 Matched Controls; A Population-Based Study

Eighteen Years Experience of Granulocyte Donations - Acceptable Donor Safety?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only